Mehilainen InMedica, UAB - employees and salaries

Company age: 1 y. 7 mo.

Update

Mehilainen InMedica - Basic salary and employee information

Number of employees

7

Annual change in number of employees

+600% (+6)

Average salary

6049 €

Salary compared to sector average

156%

6 049 € vs 3 873 € sect.

Annual employee turnover

Employee turnover rate = (number of employees who left during the year / average annual number of employees) x 100 %

0,0 %

Number of employees

Employee turnover rate

Employee turnover is a term describing the process when employees leave an organization and are replaced by new ones. It is an important human resource management indicator reflecting the quality of the company's work environment, employee satisfaction, and organizational culture.

Employee turnover rate = (number of employees who left during the year / average annual number of employees) x 100 %

Average salary

Overview of company employees and salaries

This description was generated by artificial intelligence for the end of 2025. Report if inaccurate.
Mehilainen InMedica, UAB (company code 307107342) is a Micro-sized company operating in activities of holding companies. Its average workforce increased from 3 employees in 2025 to 7 employees so far in 2026, showing a clear expansion in a very small team. Because the headcount is low, the year-on-year increase should be read as a qualitative sign of growth rather than as a broad staffing trend. Average monthly gross wages also moved up significantly, from €4,477.07 in 2025 to €6,830.83 so far in 2026, which corresponds to wage growth of 52.6%. Based on the latest average staffing level and wage data, the estimated annual payroll is about €573.8K. Overall, the available figures suggest that the company has become larger and more expensive in staffing terms during the latest reporting period, while still remaining a very small employer.

We can offer mass generation of descriptions and translations using artificial intelligence technologies for your business as well. Read more.